Back to: FDA Regulatory Education for Industry (REdI) 2024 Conference – Devices Track
Presenter
Kim Piermatteo, MHA
Commander, United States Public Health Service
Education Program Administrator
Division of Industry and Consumer Education (DICE)
Office of Communication and Education (OCE)
Center for Devices and Radiological Health (CDRH)
U.S. Food and Drug Administration (FDA)
CDR Kimberly Piermatteo is a Commissioned officer in the United States Public Health Service and currently serves in the Center for Devices and Radiological Health’s Office of Communication and Education, Division of Industry and Consumer Education as the Education Program Administrator who is responsible for leading and directing the CDRH External Webinar Program. She has been with the FDA in various capacities since 2006 spanning premarket review and postmarket adverse event and compliance work. CDR Piermatteo received her Bachelor of Science degree in Engineering Science and Minors in Bioengineering and Mathematics from the Pennsylvania State University and her Master of Health Administration (MHA) from the University of Maryland.
Abstract
At the 2024 FDA Regulatory Education for Industry Conference, Kim Piermatteo, emphasizes the power of curiosity and creativity in medical device development. Drawing inspiration from her children’s endless questions, she encourages attendees to approach medical innovation with a child-like sense of possibility, undeterred by the challenges along the way. She defines innovation as the process of bringing new ideas, methods, or products to life that have a significant positive impact, urging professionals to untangle complex challenges and transform creative concepts into practical, impactful solutions. Piermatteo encourages attendees to actively learn from the conference’s diverse topics, apply their newfound knowledge to their work, and embrace the mission to innovate in ways that improve patient care and public health. She outlines the conference structure—two sessions in the morning, a lunch break, and four more sessions in the afternoon—highlighting opportunities for interactive Q&A, knowledge checks, and discussions to advance understanding of medical device regulations and the regulatory landscape. Closing with a call to action, she urges participants to “learn, apply, and innovate,” using FDA resources and feedback to bring bold, new ideas to fruition and elevate the field of medical device development.